2010
DOI: 10.1152/ajpcell.00492.2009
|View full text |Cite
|
Sign up to set email alerts
|

Neuronal expression of sodium/bicarbonate cotransporter NBCn1 (SLC4A7) and its response to chronic metabolic acidosis

Abstract: The sodium-bicarbonate cotransporter NBCn1 (SLC4A7) is an acid-base transporter that normally moves Na(+) and HCO(3)(-) into the cell. This membrane protein is sensitive to cellular and systemic pH changes. We examined NBCn1 expression and localization in the brain and its response to chronic metabolic acidosis. Two new NBCn1 antibodies were generated by immunizing a rabbit and a guinea pig. The antibodies stained neurons in a variety of rat brain regions, including hippocampal pyramidal neurons, dentate gyrus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
57
0
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(64 citation statements)
references
References 41 publications
3
57
0
1
Order By: Relevance
“…However, in view of our localization data (Jacobs et al, 2008) and unpublished data from our laboratory, Slc4a10 appears to be the more likely candidate. Similar to Slc4a10, the Na ϩ -HCO 3 Ϫ cotransporter Slc4a7, which also mediates acid extrusion, has been found to be localized to the postsynaptic side (Park et al, 2010), whereas it has been suggested that the Na ϩ /H ϩ exchanger Slc9a1 is present in presynaptic nerve endings (Jang et al, 2006;Dietrich and Morad, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…However, in view of our localization data (Jacobs et al, 2008) and unpublished data from our laboratory, Slc4a10 appears to be the more likely candidate. Similar to Slc4a10, the Na ϩ -HCO 3 Ϫ cotransporter Slc4a7, which also mediates acid extrusion, has been found to be localized to the postsynaptic side (Park et al, 2010), whereas it has been suggested that the Na ϩ /H ϩ exchanger Slc9a1 is present in presynaptic nerve endings (Jang et al, 2006;Dietrich and Morad, 2010).…”
Section: Discussionmentioning
confidence: 99%
“…At the level of subregions of the central nervous system, NBCn1 transcripts (755) and protein (174,709) are widespread, being present in the cerebral cortex, hippocampus, subcortex, cerebellum, and olfactory bulb of rodents. NBCn1 immunoreactivity in wild-type rats and ␤-galactosidase staining of heterozygous mice with a lacZ insertion in the Slc4a7 gene shows that the highest level of NBCn1 promoter activity, at the tissue level, is in the pyramidal cell layers of the hippocampus, appearing equally robust in the CA1, CA2, and CA3 regions, and in the granule cells layer of the dentate gyrus (91,709).…”
Section: I) Central Nervous System A) Brainmentioning
confidence: 99%
“…NBCn1 immunoreactivity in wild-type rats and ␤-galactosidase staining of heterozygous mice with a lacZ insertion in the Slc4a7 gene shows that the highest level of NBCn1 promoter activity, at the tissue level, is in the pyramidal cell layers of the hippocampus, appearing equally robust in the CA1, CA2, and CA3 regions, and in the granule cells layer of the dentate gyrus (91,709). In these "lacZ" mice, NBCn1 promoter activity is also evident in certain regions of the cortex and the dentate nucleus of the cerebellum (91).…”
Section: I) Central Nervous System A) Brainmentioning
confidence: 99%
“…It is shared by the NBCn1 protein expressed in various regions of the brain (26). This effect seems to be related, at least in part, to a higher mRNA abundance (26).…”
mentioning
confidence: 99%
“…It is shared by the NBCn1 protein expressed in various regions of the brain (26). This effect seems to be related, at least in part, to a higher mRNA abundance (26). NBCn1 has also been found expressed in osteoclasts, but not in osteoblasts or osteocytes, and localized to the ruffled border facing the trabeculae, where its expression increases during metabolic acidosis, a condition known to elicit an osteoclast-dependent increase in bone resorption (28).…”
mentioning
confidence: 99%